Business Segments GSK plc

Equities

Market Closed - London S.E. Other stock markets 16:35:05 13/03/2026 GMT			5-day change	1st Jan Change
2,031.00 ^GBX	0.00%		-0.34%	+11.32%

03-13	GSK and Amgen to add medicines to TrumpRx, Fox Business reports	RE
03-13	GSK plc Announces Expansion of AREXVY Approval to Adults Aged 18 to 49 Years for RSV Prevention	CI

Breakdown by Business Segment (GBP)

Fiscal Period: December	2021	2022	2023	2024	2025
Biological Products
Commercial Operations	-	29.32B	30.33B	31.38B	32.67B
D&A	-	829M	893M	906M	874M
Operating Income	-	13.59B	14.66B	15.34B	16.26B
Corporate and Other Unallocated Turnover	-	-	-	-	-
Operating Income	-370M	-379M	-263M	-342M	-226M
D&A	54M	112M	110M	74M	79M
D&A	802M	739M	719M	1B	808M
Dental Care Products
Consumer Healthcare	9.61B	-	-	-	-
D&A	226M	-	-	-	-
Operating Income	2.24B	-	-	-	-
Pharmaceutical Research and Development
D&A	325M	467M	572M	569M	553M
Operating Income	-3.49B	-5.06B	-5.61B	-5.84B	-6.25B
Pharmaceutical Products
Vaccines	6.78B	-	-	-	-
D&A	416M	-	-	-	-
Operating Income	2.26B	-	-	-	-
Pharmaceuticals	17.73B	-	-	-	-
D&A	553M	-	-	-	-
Operating Income	8.17B	-	-	-	-

Geographical breakdown of sales (GBP)

Fiscal Period: December	2021	2022	2023	2024	2025
United States (US)	15.09B	14.54B	15.82B	16.38B	16.86B
Total Assets	17.85B	14.02B	13.28B	13.98B	14.52B
Operating Income	-	-	-	-	-
Rest of World	18.05B	14.09B	13.82B	14.28B	8.28B
Total Assets	15.39B	6.56B	6.61B	5.59B	5.53B
Operating Income	-	-	-	-	-
Europe	-	-	-	-	6.85B
United Kingdom (UK)	975M	695M	693M	708M	683M
Total Assets	6.62B	5.13B	6.46B	7.8B	8.47B
Operating Income	-	-	-	-	-
Total Assets	5.06B	5.42B	5.34B	5.38B	5.45B
Total Assets	6.55B	34M	-	-	-
Inter-Segment Turnover	-	-	-	-	-